Patent · US Active

DNA2 inhibitors for cancer treatment

US11780815B2 · kind B2 · utility

0Cited by

8References

14Claims

0Family size

Assignees

City of Hope · US
CALIFORNIA INSTITUTE OF TECHNOLOGY · US

Inventors

Binghui Shen · Duarte, US
Judith Campbell · Sierra Madre, US
Li Zheng · Beijing, CN
Hongzhi Li · New York, US
David Horne · Duarte, US
Jun Xie · Singapore, SG
Kenneth Karanja · Maple Grove, US

Key dates

Filing date	Oct 29, 2021
Grant date	Oct 10, 2023
Priority date	—
Expiry date	Mar 18, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein, inter alia, are compositions and methods for inhibiting DNA2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.